Negative 10.2% Revenue Growth Reverses to Positive by Q1 2025
16.6x Fwd P/E Expands to 18x by Q3 2025 on Underwriting Profitability
Enhanced Capital Returns Drive Share Price 10% Higher by Q4 2024